26 febrero 2015
A controlled-release oral therapy has been developed by scientists that reversed type 2 diabetes and fatty liver disease in rats, according to a study. «Given these promising results in animal models of NAFLD/NASH and type 2 diabetes we are pursuing additional preclinical safety studies to take this mitochondrial protonophore approach to the clinic» said the researchers.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/G5bg6QA91i4/150226144905.htm
